Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
02/2012
02/29/2012CN102365269A Novel therapeutic agent for cognitive impairment
02/29/2012CN102363633A Glucagon like peptide-1 mutant polypeptide and preparation method, medicinal composition and use thereof
02/29/2012CN102362994A Zinc gluconate oral liquid for strengthening spleen and stomach
02/29/2012CN102362973A Medicinal composition for treating calciprivia in children and preparation method thereof
02/29/2012CN102362927A Traditional Chinese medicine for treating hyperlipemia
02/29/2012CN102362903A Traditional Chinese medicine for treating hyperlipidemia
02/29/2012CN102362886A Use of extract of liquoric root Chinese herbal medicine in preparation of medicines for reducing weight and fat or medicines capable of inhibiting activity of lipase
02/29/2012CN102362866A Medicinal composition for treating diabetes and obesity
02/29/2012CN102362864A Method for raising free-flowing property and bulk density of vitamin A or vitamin D3 microcapsules
02/29/2012CN102362863A Orlistat-containing preparation and preparation method thereof
02/29/2012CN102362862A Double-layer sustained-release tablet for reducing blood fat coordinately
02/29/2012CN101919831B Method for inhibiting content decrease of Vit K1 after sterilization
02/29/2012CN101912407B Weight-reducing and lipid-lowering composition
02/29/2012CN101879158B New application of artemisinin derivant
02/29/2012CN101838337B Fructan consisting of 25 fructoses and 1 glucose
02/29/2012CN101785800B Traditional Chinese medicine combination for hepatopathy treatment
02/29/2012CN101745048B Medicine for treating type II diabetes and resisting aging
02/29/2012CN101735286B Amino acid modified glucosamine as well as preparation method and application thereof
02/29/2012CN101679309B Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound
02/29/2012CN101574347B Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing
02/29/2012CN101554396B Traditional Chinese medicine for treating diabetes and hyperlipidemia
02/29/2012CN101496818B Kidney-nourishing and bone-tonifying chewable tablet and preparation method thereof
02/29/2012CN101480472B Medicament for reducing blood pressure and regulating blood fat and production method
02/29/2012CN101400659B Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
02/29/2012CN101268063B Thiophene derivatives for the treatment of diabetes
02/29/2012CN101185642B Glucosamine lysine selenium salt and production process
02/28/2012US8124830 Transgenic non-human animals expressing a truncated activin type II receptor
02/28/2012US8124638 Tricyclic compounds useful as angiotensin II agonists
02/28/2012US8124589 Use of ketogenic compounds for treatment of age-associated memory impairment
02/28/2012US8124585 Composition for relieving discomfort
02/28/2012US8124356 Methods of purifying zsig33
02/28/2012US8124122 Female hormone-containing patch
02/28/2012US8124081 Using amyloid A specific immunoglobulin for use in prevention and treatment of infection, nervous system, cell proliferative and inflammatory disorders
02/23/2012WO2012024638A2 Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
02/23/2012WO2012024559A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
02/23/2012WO2012024270A1 Nutritional composition comprising cereal beta-glucan and salacia extract
02/23/2012WO2012024223A2 Combination therapy with anti-cd74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases
02/23/2012WO2012024161A1 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists
02/23/2012WO2012023803A2 Composition for preventing and treating complications of diabetes mellitus, containing brandisia hancei hook. f. extract or fraction thereof as active ingredient
02/23/2012WO2012023623A2 Agent for treatment of hunter syndrome
02/23/2012WO2012023600A1 4-isopropyl-6-methoxyphenyl glucitol compound
02/23/2012WO2012023599A1 Process for production of triterpene alcohol
02/23/2012WO2012023582A1 4-isopropylphenyl glucitol compound
02/23/2012WO2012022780A1 18-beta-glycyrrhetinic acid derivatives with anti-tumor activity
02/23/2012WO2012022341A1 Composition and use thereof for reducing body weight and/or improving endurance during and regeneration after a physical activity is performed
02/23/2012WO2012021981A1 Novel phytochemicals from extracts of maple syrups and maple trees and uses thereof
02/23/2012WO2012003554A3 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates
02/23/2012WO2011163533A3 One step removal of selected molecules from body fluid and tissue
02/23/2012WO2011140232A3 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
02/23/2012WO2011119649A3 Pharmaceutical compositions containing berberine for treatment or prevention of weight gain and obesity associated with anti-psychotic drugs
02/23/2012WO2011115447A3 C-terminal truncated peroxiredoxin-ii, and composition for preventing and treating apoptosis containing same
02/23/2012US20120046366 Extractions of Fixed Oil and Thymoquinone Rich Fractions (TQRF)
02/23/2012US20120046364 Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
02/23/2012US20120046361 Ethyl pyruvate compositions and methods
02/23/2012US20120046360 Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
02/23/2012US20120046357 Benzamide and Napthamide Derivatives Inhibiting Nuclear Factor-Kappa (B) - (NK-kB)
02/23/2012US20120046350 Novel compounds, their preparation and use
02/23/2012US20120046347 Expression of apoai and variants thereof using spliceosome mediated rna trans-splicing
02/23/2012US20120046344 Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
02/23/2012US20120046338 Fused cyclic compounds
02/23/2012US20120046330 Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d] [1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
02/23/2012US20120046329 Modulators of nod1 and nod2 signaling, methods of identifying modulators of nod1 and nod2 signaling, and uses thereof
02/23/2012US20120046325 Isoxazoline Compounds Having MIF Antagonist Activity
02/23/2012US20120046324 Small molecule inhibitors of kynurenine-3-monooxygenase
02/23/2012US20120046322 Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex
02/23/2012US20120046311 Chemokine receptor antagonists and methods of use thereof
02/23/2012US20120046308 Novel alpha-phenoxybenzeneacetic acid derivative and pharmaceutical preparation comprising same
02/23/2012US20120046307 Allosteric protein kinase modulators
02/23/2012US20120046304 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
02/23/2012US20120046303 Benzimidazole poly(adp ribose)polymerase inhibitors
02/23/2012US20120046301 Substituted Cyclic Carboxamide and Urea Derivatives as Ligands of the Vanilloid Receptor
02/23/2012US20120046292 Diacylethylenediamine compound
02/23/2012US20120046289 Pyridazine Carboxamide Orexin Receptor Antagonists
02/23/2012US20120046280 Novel heteropyrrole analogs acting on cannabinoid receptors
02/23/2012US20120046269 Novel Amino Azaheterocyclic Carboxamides
02/23/2012US20120046262 Megestrol acetate products, method of manufacture, and method of use
02/23/2012US20120046257 Methods for Administration and Formulations for the Treatment of Regional Adipose Tissue
02/23/2012US20120046256 Lipolytic Methods for Regional Adiposity Comprising Salmeterol or Formoterol
02/23/2012US20120046255 Non-steroidal compounds
02/23/2012US20120046254 Dispersion of phytosterols
02/23/2012US20120046252 Calcium Formate for Use as a Dietary Supplement
02/23/2012US20120046236 Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
02/23/2012US20120046225 Stable glucagon formulations for the treatment of hypoglycemia
02/23/2012US20120046224 Treatment of diabetes and metabolic syndrome
02/23/2012US20120046222 N-terminus conformationally constrained glp-1 receptor agonist compounds
02/23/2012US20120046221 Albumin fusion proteins
02/23/2012US20120046219 Melanocortin receptor-specific peptides
02/23/2012US20120046217 TNF-alpha Antagonists Containing IGFBP5
02/23/2012US20120045517 TREATMENT OF CELIAC DISEASE WITH IgA
02/23/2012US20120045509 Modified release compositions for dpp-iv inhibitors
02/23/2012US20120045503 Compositions And Methods For Wound Healing
02/23/2012US20120045499 Pearlescent pigment surface treatment for confectionery
02/23/2012US20120045483 Mannitol and/or Proline for Prevention and Treatment of Ageing Related Symptoms
02/23/2012US20120045482 Policosanol nanoparticles
02/23/2012US20120045460 Methods and compositions for treatment of graft rejection and promotion of graft survival
02/23/2012US20120045459 Methods for Treating Autophagy-Related Disorders
02/23/2012US20120045452 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
02/23/2012US20120045451 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
02/23/2012US20120045441 Methods of treating lung disease and other inflammatory diseases
02/23/2012US20120045438 Engineered anti-il-13 antibodies, compositions, methods and uses
1 ... 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 ... 1298